# The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

> **NCT00298194** · PHASE2 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 52 (estimated)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Z-338

## Key facts

- **NCT ID:** NCT00298194
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2009-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298194, "The Effects of Z-338 in Subjects With and Without Functional Dyspepsia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00298194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*